Macquarie Group LTD Celldex Therapeutics, Inc. Transaction History

Macquarie Group LTD

  • $90.3 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 14, 2022
SELL
$22.7 - $37.57 $21,383 - $35,390
-942 Closed
0 $26,000
Q3 2021

Nov 12, 2021
BUY
$28.95 - $55.99 $27,270 - $52,742
942 New
942 $51,000
Q1 2021

May 14, 2021
SELL
$16.19 - $29.91 $78,910 - $145,781
-4,874 Closed
0 $0
Q4 2020

Feb 16, 2021
BUY
$14.99 - $22.75 $73,061 - $110,883
4,874 New
4,874 $85,000

Others Institutions Holding CLDX

# of Institutions
203
Shares Held
67.3M
Call Options Held
1.69M
Put Options Held
980K
View Full List

About Celldex Therapeutics, Inc.

CLDX Quotes by TradingView
  • Ticker CLDX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 46,772,400
  • Market Cap $1.06B
  • Description
  • Celldex Therapeutics, Inc., a biopharmaceutical company, engages in developing therapeutic monoclonal and bispecific antibodies for the treatment of various diseases. Its drug candidates include antibody-based therapeutics to treat patients with inflammatory diseases and various forms of cancer. The company's clinical development programs CDX-01...
More about CLDX
Track This Portfolio

Track Macquarie Group LTD Portfolio

Follow Macquarie Group LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Macquarie Group LTD, based on Form 13F filings with the SEC.

News

Stay updated on Macquarie Group LTD with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email